Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Soy genistein in mice

This article was originally published in The Tan Sheet

Executive Summary

"Use of soy formula for infant nutrition and high soy/isoflavone intake by adults through the use of supplements needs to be approached with caution," according to study appearing in May 28 Proceedings of the National Academy of Sciences. Srikanth Yellayi, et al., University of Illinois-Urbana, injected mice with genistein in doses ranging from 2-200 mg/kg per day and found the soy isoflavone produced dose-responsive reductions in thymic weight and size of up to 78% compared with control groups. Genistein also was found to impair humoral immunity and could inhibit immune function, researchers note. Yellayi et al. conclude "large-scale studies addressing immune function or morbidity in soy fed infants are needed to conclusively determine" if there are abnormalities associated with soy formula consumption...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094068

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel